이스라엘 - 영어 - Ministry of Health

rafa laboratories ltd - benzoyl peroxide - gel - benzoyl peroxide 2.5 %w/w - benzoyl peroxide - benzoyl peroxide - for the topical treatment of acne vulgaris.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - benzoyl peroxide, quantity: 50 mg/g - gel - excipient ingredients: carbomer 940; glycerol; docusate sodium; propylene glycol; sodium hydroxide; purified water; disodium edetate; poloxamer; acrylates copolymer; colloidal anhydrous silica - treatment of acne.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - benzoyl peroxide, quantity: 25 mg/g - gel - excipient ingredients: colloidal anhydrous silica; disodium edetate; propylene glycol; purified water; docusate sodium; poloxamer; glycerol; carbomer 940; sodium hydroxide; acrylates copolymer - for use as an aid in the treatment of acne.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

galderma australia pty ltd - benzoyl peroxide, quantity: 100 mg/g - gel - excipient ingredients: disodium edetate; propylene glycol; docusate sodium; carbomer 940; sodium hydroxide; purified water; glycerol; acrylates copolymer; colloidal anhydrous silica; poloxamer - treatment of acne.

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

neo health (otc) pty ltd - benzoyl peroxide, quantity: 50 mg/g - cream - excipient ingredients: purified water; colloidal anhydrous silica; citric acid monohydrate; glycerol; sodium lauryl sulfate; cetyl alcohol; propyl hydroxybenzoate; methyl hydroxybenzoate; propylene glycol; sodium citrate dihydrate; glyceryl monostearate; peg-100 stearate - for the treatment of acne.

몰타 - 영어 - Medicines Authority

glaxo smithkline uk limited - benzoyl peroxide; clindamycin - gel - benzoyl peroxide 30 mg/g; clindamycin 10 mg/g - anti-acne preparations

몰타 - 영어 - Medicines Authority

glaxo smithkline uk limited - benzoyl peroxide; clindamycin - gel - benzoyl peroxide 50 mg/g; clindamycin 10 mg/g - anti-acne preparations

미국 - 영어 - NLM (National Library of Medicine)

cutanea life sciences, inc. - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - erythromycin 30 mg in 1 g - aktipak®  is indicated for the topical treatment of acne vulgaris. aktipak®  is contraindicated in those individuals who have shown hypersensitivity to any of its components.

미국 - 영어 - NLM (National Library of Medicine)

lyne laboratories, inc. - erythromycin (unii: 63937kv33d) (erythromycin - unii:63937kv33d) - erythromycin 30 mg in 1 g

미국 - 영어 - NLM (National Library of Medicine)

prasco laboratories - clindamycin phosphate (unii: eh6d7113i8) (clindamycin - unii:3u02el437c), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - clindamycin 10 mg in 1 g - clindamycin phosphate and benzoyl peroxide gel, 1.2%/5% is indicated for the topical treatment of inflammatory acne vulgaris in patients 12 years and older. clindamycin phosphate and benzoyl peroxide gel, 1.2%/5% has not been demonstrated to have any additional benefit when compared with benzoyl peroxide alone in the same vehicle when used for the treatment of non-inflammatory acne. clindamycin phosphate and benzoyl peroxide gel, 1.2%/5% is contraindicated in those individuals who have shown hypersensitivity to clindamycin, benzoyl peroxide, any components of the formulation, or lincomycin. anaphylaxis, as well as allergic reactions leading to hospitalization, has been reported in postmarketing use with clindamycin phosphate and benzoyl peroxide gel, 1.2%/5%. [see adverse reactions (6.2).] clindamycin phosphate and benzoyl peroxide gel, 1.2%/5% is contraindicated in those individuals with a history of regional enteritis, ulcerative colitis, pseudomembranous colitis, or antibiotic-associated colitis [see warni